Clinical Perspectives on Cochlear Implantation in Pediatric Patients with Cochlear Nerve Aplasia or Hypoplasia

Ava Raynor1, Sara Perez2, Megan Worthington2

  • 1Children's Hospital of Philadelphia, 3401 Civic Center Blvd, Philadelphia, PA 19104, USA.

Audiology Research
|August 27, 2025
PubMed

Insights

Hearing professionals in the USA often prefer cochlear implantation (CI) for children with cochlear nerve deficiencies (CND). However, there

Area of Science:

  • Otolaryngology
  • Audiology
  • Pediatric Medicine

Background:

  • Cochlear implantation (CI) for pediatric cochlear nerve deficiencies (CND) is debated due to patient variability and inconsistent guidelines.
  • Current practices for CI candidacy in children with CND in the USA are not well-defined.

Purpose of the Study:

  • To evaluate US hearing healthcare professionals' perspectives on CI candidacy for children with CND.
  • To understand current practices, including imaging and outcome expectations, for CI versus auditory brainstem implant (ABI) in pediatric CND cases.

Main Methods:

  • An anonymous online survey with 19 questions was distributed to CI clinicians nationwide.
  • Survey data included professional background, experience with cochlear aplasia/hypoplasia, and views on CI/ABI candidacy.
  • Both multiple-choice and open-ended responses were analyzed.

Main Results:

  • Most clinicians favored CI for hypoplasia (60.2%) and aplasia (41.7%), with audiologists more likely than neurotologists to support CI.
  • Reasons for preferring CI over ABI included lower risk, accessibility, and potential benefit.
  • A case-by-case approach, integrating imaging, electrophysiology, and counseling, was emphasized, but only 22.2% viewed structural factors as key predictors of success.

Conclusions:

  • US hearing health professionals generally favor CI as a primary option for pediatric CND, despite diagnostic tool limitations.
  • Significant variability exists in clinical perspectives on CI for pediatric aplasia and hypoplasia, indicating a lack of consensus.
  • There is a need for standardized assessment and imaging protocols to improve consistency and develop evidence-based guidelines.

Related Concept Videos

Clinical Applications of Epidermal Stem Cells01:19

Clinical Applications of Epidermal Stem Cells

Epidermal stem cells (EpiSCs) are mainly located at the basal layer of the epidermis. These cells repair minor injuries of the skin and replace dead skin cells. However, EpiSCs’ cannot heal severe wounds such as major burns or those from diabetes or hereditary disorders. In such cases, culturing the epidermal stem cells from the patient is possible and has yielded successful treatment options, such as laboratory-grown skin grafts. These grafts are synthesized using a patient’s own...
2.4K
Tissue Transplantation01:24

Tissue Transplantation

Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
1.4K
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids01:21

Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids

Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2...
692
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
967
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
554
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
408